ConductScience.org, home

Paper12876172

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.

Byrne NM and 4 others. Arch Dis Child, 2003. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Papers, record 12876172. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12876172

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.
PubMed
Journal
Arch Dis Child
PubMed
Year
2003
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.18
iCite
Revised in PubMed
2019-05-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Byrne NMN M
2Keavey PMP M
3Perry JDJ D
4Gould FKF K
5Spencer DAD A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
ColistinMajor topic
Cystic FibrosisMajor topic
LungMajor topic
Nebulizers and VaporizersMajor topic
Pseudomonas InfectionsMajor topic
Administration, Inhalation
Adolescent
Adult
Child
Cross-Over Studies
Humans
Opportunistic Infections
Radiopharmaceuticals
Sputum
Technetium Tc 99m Pentetate

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in12876155Ethical aspects of using radiolabelling in aerosol research.https://conductscience.org/library/papers/12876155

Source PubMed

Download CSV of comments and corrections

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111316693Bronchoconstriction following nebulised colistin in cystic fibrosis.Arch Dis Child2001https://conductscience.org/library/papers/11316693PubMed
26118579Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.Lancet1981https://conductscience.org/library/papers/6118579PubMed
36981383Pseudomonas infection, allergy, and cystic fibrosis.Arch Dis Child1982https://conductscience.org/library/papers/6981383PubMed
42858720Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis.Lancet1985https://conductscience.org/library/papers/2858720PubMed
52090472Bronchial response to nebulized antibiotics in children with cystic fibrosis.Eur Respir J1990https://conductscience.org/library/papers/2090472PubMed
61679870Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.Lancet1991https://conductscience.org/library/papers/1679870PubMed
78497819Lung deposition of nebulised pentamidine in children.Thorax1993https://conductscience.org/library/papers/8497819PubMed
88128399Treatment compliance in adults with cystic fibrosis.Thorax1994https://conductscience.org/library/papers/8128399PubMed
98575589Inhalation of antibiotics in cystic fibrosis.Eur Respir J1995https://conductscience.org/library/papers/8575589PubMed
108658364Compliance with treatment in adult patients with cystic fibrosis.Thorax1996https://conductscience.org/library/papers/8658364PubMed
118733486Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.Thorax1996https://conductscience.org/library/papers/8733486PubMed
129246141Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.Thorax1997https://conductscience.org/library/papers/9246141PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
37942828Nebuliser systems for drug delivery in cystic fibrosis.Cochrane Database Syst Rev2023https://conductscience.org/library/papers/37942828PubMed
35322119Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment.Sci Rep2022https://conductscience.org/library/papers/35322119PubMed
27822851SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study.Pharm Res2017https://conductscience.org/library/papers/27822851PubMed
26040660Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.Pharm Res2015https://conductscience.org/library/papers/26040660PubMed
25278817Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.Core Evid2014https://conductscience.org/library/papers/25278817PubMed
24550334Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24550334PubMed
20373907Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.J Aerosol Med Pulm Drug Deliv2010https://conductscience.org/library/papers/20373907PubMed
20183916Inhaled drug delivery for tuberculosis therapy.Pharm Res2009https://conductscience.org/library/papers/20183916PubMed
14586053Lymphangioleiomyomatosis: a case-control study of perinatal and early life events.Thorax2003https://conductscience.org/library/papers/14586053PubMed
12876155Ethical aspects of using radiolabelling in aerosol research.Arch Dis Child2003https://conductscience.org/library/papers/12876155PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12876172

GET https://conductscience.org/api/papers/v1/12876172/authors